Sona Nanotech Inc C.SONA

Alternate Symbol(s): SNANF

Healthcare Biotechnology

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.

CSE:SONA - Post by User

Sona Nanotech Inc

Bullboard Posts

Comment by oxinoson Oct 06, 2020 1:16pm

136 Views

Post# 31674033

RE:RE:Health Canada approves another Abbott test

You are correct with regard to when the test you are talking about can detect the virus. But this is not the test that was approved. It was from a subsidiary of Abbott labs in Germany and the antigen test is called Panbio. This is not the Binax now test.

Bullboard Posts

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal